Department of Ophthalmology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1384-91. doi: 10.1167/iovs.10-6509. Print 2011 Mar.
Photoreceptor degeneration is a major cause of visual loss in various retinal diseases, including retinal detachment (RD) and neovascular AMD, but the underlying mechanisms remain elusive. In this study, the role of TNFα in RD-induced photoreceptor degeneration was investigated.
RD was induced by subretinal injection of hyaluronic acid. Photoreceptor degeneration was assessed by counting the number of apoptotic cells with TdT-dUTP terminal nick-end labeling (TUNEL) 3 days after RD and measurement of the outer nuclear layer (ONL) thickness 7 days after RD. As the target of anti-inflammatory treatment, the expression of TNFα, with or without dexamethasone (DEX) was examined in rats by real-time PCR. To understand the role of TNFα in photoreceptor degeneration, RD was induced in mice deficient in TNFα or its receptors (TNFR1, TNFR2, and TNFR1 and -2), or in wild-type (WT) mice by using a functionally blocking antibody to TNFα. CD11b(+) cells in the outer plexiform layer (OPL) and subretinal space were counted by immunohistochemistry (IHC).
Treatment with DEX (P = 0.001) significantly suppressed RD-induced photoreceptor degeneration and the expression of TNFα. RD-induced photoreceptor degeneration was significantly suppressed with specific blockade of TNFα (P = 0.032), in mice deficient for TNFα (P < 0.001), TNFR2 (P = 0.001), or TNFR1 and -2 (P < 0.001). However, lack of TNFR1 did not protect against RD-induced photoreceptor degeneration (P = 0.060). Müller cell activation was unchanged in WT and TNFα(-/-) mice. Recruitment of CD11b(+) monocytes was significantly lower in the TNFα(-/-) mice compared to WT mice (P = 0.002).
TNFα plays a critical role in RD-induced photoreceptor degeneration. This pathway may become an important target in the prevention of RD-induced photoreceptor degeneration.
光感受器变性是包括视网膜脱离 (RD) 和新生血管性 AMD 在内的各种视网膜疾病导致视力丧失的主要原因,但潜在机制仍不清楚。本研究探讨了 TNFα 在 RD 诱导的光感受器变性中的作用。
通过视网膜下注射透明质酸诱导 RD。用 TdT-dUTP 末端标记 (TUNEL) 法在 RD 后 3 天计数凋亡细胞数,在 RD 后 7 天测量外核层 (ONL) 厚度,评估光感受器变性。用实时 PCR 检测作为抗炎治疗靶点的 TNFα 的表达,以及是否存在地塞米松 (DEX)。为了了解 TNFα 在光感受器变性中的作用,用 TNFα 及其受体 (TNFR1、TNFR2 和 TNFR1 和 -2) 缺失的小鼠或用 TNFα 的功能阻断抗体在野生型 (WT) 小鼠中诱导 RD。用免疫组织化学 (IHC) 计数外丛状层 (OPL) 和视网膜下间隙中的 CD11b(+)细胞。
DEX 治疗 (P = 0.001) 显著抑制 RD 诱导的光感受器变性和 TNFα 的表达。用 TNFα 特异性阻断剂 (P = 0.032)、TNFα 缺失 (P < 0.001)、TNFR2 缺失 (P = 0.001) 或 TNFR1 和 -2 缺失 (P < 0.001) 均显著抑制 RD 诱导的光感受器变性。然而,TNFR1 缺失并不能防止 RD 诱导的光感受器变性 (P = 0.060)。WT 和 TNFα(-/-) 小鼠的 Müller 细胞激活无变化。与 WT 小鼠相比,TNFα(-/-) 小鼠中 CD11b(+)单核细胞的募集显著降低 (P = 0.002)。
TNFα 在 RD 诱导的光感受器变性中起关键作用。该途径可能成为预防 RD 诱导的光感受器变性的重要靶点。